Product approvals

Explore the landscape of product approvals in China’s pharmaceutical industry. Fineline Info & Tech delivers reliable data and insights on product approvals to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Roche Inks Exclusive Worldwide License With Rona Therapeutics for ALK7‑Targeting RNAi Candidate – Up to USD 1.16 Billion Deal Advances Genetically Validated Obesity Target via Extrahepatic Delivery
CompanyDeals

Roche Inks Exclusive Worldwide License With Rona Therapeutics for ALK7‑Targeting RNAi Candidate – Up to USD 1.16 Billion Deal Advances Genetically Validated Obesity Target via Extrahepatic Delivery

Roche (SWX: ROP; OTCMKTS: RHHBY) announced an exclusive worldwide licensing agreement with Rona Therapeutics to develop an investigational RNA interference (RNAi) candidate targeting activin receptor‑like kinase 7 (ALK7), built on…

Sinocelltech's SCT810 Injection Wins NMPA Clearance for Phase I/II Study – Anti‑TFPI Antibody Offers Factor‑Independent Prophylaxis for Hemophilia A and B With or Without Inhibitors

Sinocelltech’s SCT810 Injection Wins NMPA Clearance for Phase I/II Study – Anti‑TFPI Antibody Offers Factor‑Independent Prophylaxis for Hemophilia A and B With or Without Inhibitors

Insilico Medicine Nominates ISM9546 as Preclinical Candidate – Oral, Peripherally Restricted VAV1 Molecular Glue Degrader Targets IBD and Rheumatoid Arthritis

Insilico Medicine Nominates ISM9546 as Preclinical Candidate – Oral, Peripherally Restricted VAV1 Molecular Glue Degrader Targets IBD and Rheumatoid Arthritis

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDrug

Luye Pharma’s Biosimilar LY06006/BA6101 Approved for Osteoporosis Treatment

CompanyDrug

BeiGene’s Brukinsa Receives Marketing Approval in Brazil

CompanyDrug

NMPA Conditionally Approves Yingli Pharma’s Linperlisib for Lymphoma

CompanyDrug

Merck’s Keytruda Receives 10th Indication Approval in China for TNBC

CompanyDrug

Sinovac’s Varicella Vaccine Receives WHO Pre-Qualification

CompanyDrug

BeiGene’s Brukinsa Receives EU Marketing Approval for Marginal Zone Lymphoma

CompanyMedical Device

Sino Medical Sciences’ Non-Compliant Balloon Catheter Approved by NMPA

CompanyDrug

NMPA Approves Luye Pharma’s LY03005 for Depression Treatment

Show More